# Quantum X Labs Inc.: filings

QXL · Nasdaq · CIK 797542 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qxl.md) · [Financials](/companies/qxl/financials.md) · [Filings](/companies/qxl/filings.md) · [Insiders](/companies/qxl/insiders.md)

## Reports and events: 188 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 92, 10-Q 53, 3 27, 4 22, 10-K 18, UPLOAD 17, CORRESP 13, NT 10-Q 13, DEF 14C 8, PRE 14C 8, SCHEDULE 13G/A 8, 10-Q/A 6, 5 6, 8-K/A 6, S-1/A 6, NT 10-K 5, S-1 5, EFFECT 4, SC 13G 4, 3/A 3, SC 13G/A 3, SCHEDULE 13G 3, 424B3 2, D 2, DEFA14C 2, S-3 2, 8-A12B 1, 8-K12G3 1, 8-K12G3/A 1, CERT 1, DEL AM 1, PRER14C 1, RW 1, SC 13D 1, SC 13D/A 1, SC 14F1 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-22 | 16:30 ET | [8-K](/filings/0001493152-26-043718.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-043718 |
| 2026-09-15 | 07:52 ET | [8-K](/filings/0001493152-26-042665.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-042665 |
| 2026-08-13 | 16:31 ET | [10-Q](/filings/0001493152-26-037811.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037811 |
| 2026-05-29 | 08:30 ET | [8-K](/filings/0001493152-26-025728.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-025728 |
| 2026-05-15 | 16:30 ET | [8-K](/filings/0001493152-26-023849.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-023849 |
| 2026-05-14 | 17:03 ET | [10-Q](/filings/0001493152-26-023169.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023169 |
| 2026-05-14 | 16:15 ET | [8-K](/filings/0001493152-26-023096.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-023096 |
| 2026-04-30 | 09:20 ET | [8-K](/filings/0001493152-26-019787.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-019787 |
| 2026-04-21 | 09:00 ET | [8-K](/filings/0001493152-26-018217.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018217 |
| 2026-03-27 | 16:15 ET | [10-K](/filings/0001493152-26-013205.md) | Annual report, period 2025-12-31 | 0001493152-26-013205 |
| 2026-01-02 | 16:30 ET | [8-K](/filings/0001493152-26-000144.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-000144 |
| 2025-12-15 | 17:23 ET | [8-K](/filings/0001493152-25-027799.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-027799 |
| 2025-11-14 | 16:16 ET | [10-Q](/filings/0001493152-25-023501.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023501 |
| 2025-11-14 | 07:12 ET | [8-K](/filings/0001493152-25-022517.md) | 8.01 Other events | 0001493152-25-022517 |
| 2025-11-12 | 16:30 ET | [8-K](/filings/0001493152-25-021947.md) | 1.01 Entry into a material agreement | 0001493152-25-021947 |
| 2025-11-05 | 08:21 ET | [8-K](/filings/0001493152-25-020811.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-020811 |
| 2025-09-26 | 16:15 ET | [8-K](/filings/0001493152-25-015726.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-015726 |
| 2025-08-19 | 16:06 ET | [10-Q](/filings/0001641172-25-024831.md) | Quarterly report, period 2025-06-30 | 0001641172-25-024831 |
| 2025-07-23 | 16:15 ET | [S-1](/filings/0001641172-25-020700.md) | Registration statement | 0001641172-25-020700 |
| 2025-07-22 | 07:00 ET | [8-K](/filings/0001641172-25-020511.md) | 8.01 Other events | 0001641172-25-020511 |
| 2025-07-14 | 16:08 ET | [8-K](/filings/0001641172-25-019503.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-019503 |
| 2025-06-20 | 06:11 ET | [S-1](/filings/0001641172-25-015686.md) | Registration statement | 0001641172-25-015686 |
| 2025-06-11 | 18:17 ET | [8-K](/filings/0001641172-25-014584.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-014584 |
| 2025-06-09 | 16:19 ET | [8-K/A](/filings/0001641172-25-014311.md) | 9.01 Financial statements and exhibits | 0001641172-25-014311 |
| 2025-06-04 | 16:43 ET | [8-K](/filings/0001641172-25-013644.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-013644 |
| 2025-05-14 | 16:06 ET | [S-1/A](/filings/0001641172-25-010260.md) | Registration statement, amended | 0001641172-25-010260 |
| 2025-05-14 | 21:46 ET | [10-Q](/filings/0001641172-25-010059.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010059 |
| 2025-03-31 | 08:24 ET | [8-K](/filings/0001641172-25-001491.md) | 8.01 Other events | 0001641172-25-001491 |
| 2025-03-24 | 17:30 ET | [S-1/A](/filings/0001641172-25-000384.md) | Registration statement, amended | 0001641172-25-000384 |
| 2025-03-24 | 17:23 ET | [8-K](/filings/0001641172-25-000368.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-000368 |
| 2025-03-21 | 09:29 ET | [10-K](/filings/0001493152-25-011100.md) | Annual report, period 2024-12-31 | 0001493152-25-011100 |
| 2025-03-13 | 16:56 ET | [8-K](/filings/0001493152-25-010229.md) | 8.01 Other events | 0001493152-25-010229 |
| 2025-02-06 | 16:00 ET | [8-K](/filings/0001493152-25-005175.md) | 8.01 Other events | 0001493152-25-005175 |
| 2024-11-19 | 16:01 ET | [10-Q](/filings/0001493152-24-046797.md) | Quarterly report, period 2024-09-30 | 0001493152-24-046797 |
| 2024-09-13 | 09:15 ET | [8-K](/filings/0001493152-24-036128.md) | 8.01 Other events | 0001493152-24-036128 |
| 2024-08-14 | 17:04 ET | [10-Q](/filings/0001493152-24-032365.md) | Quarterly report, period 2024-06-30 | 0001493152-24-032365 |
| 2024-07-31 | 16:29 ET | [S-1](/filings/0001493152-24-029747.md) | Registration statement | 0001493152-24-029747 |
| 2024-07-31 | 16:05 ET | [8-K](/filings/0001493152-24-029736.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-029736 |
| 2024-07-30 | 09:15 ET | [8-K](/filings/0001493152-24-029529.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-029529 |
| 2024-07-22 | 16:05 ET | [8-K](/filings/0001493152-24-028685.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001493152-24-028685 |
| 2024-07-19 | 13:09 ET | [8-K](/filings/0001493152-24-028474.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-028474 |
| 2024-07-05 | 16:05 ET | [8-K](/filings/0001493152-24-026343.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001493152-24-026343 |
| 2024-06-20 | 08:32 ET | [8-K](/filings/0001493152-24-024432.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001493152-24-024432 |
| 2024-05-20 | 17:06 ET | [10-Q](/filings/0001493152-24-020755.md) | Quarterly report, period 2024-03-31 | 0001493152-24-020755 |
| 2024-04-19 | 16:05 ET | [8-K](/filings/0001493152-24-015332.md) | 8.01 Other events | 0001493152-24-015332 |
| 2024-03-25 | 16:06 ET | [10-K](/filings/0001493152-24-011132.md) | Annual report, period 2023-12-31 | 0001493152-24-011132 |
| 2023-12-12 | 16:56 ET | [8-K](/filings/0001493152-23-044578.md) | 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-044578 |
| 2023-11-14 | 16:05 ET | [10-Q](/filings/0001493152-23-041065.md) | Quarterly report, period 2023-09-30 | 0001493152-23-041065 |
| 2023-08-14 | 16:10 ET | [10-Q](/filings/0001493152-23-028454.md) | Quarterly report, period 2023-06-30 | 0001493152-23-028454 |
| 2023-08-14 | 16:06 ET | [8-K](/filings/0001493152-23-028409.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-028409 |

Page 1 of 4. [Older](/companies/qxl/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.